Muscular Dystrophy
This refers to a group of degenerative disorders which lead to skeletal muscle breakdown and weakness over time
– There are over 30 different disorders, but a few are much more common that the rest.
– Each has a different pattern on inheritance, which can be X-lined or autosomal.
General Diagnosis:
– Blood test shows raised creatinine kinase –> due to breakdown of skeletal muscle
– Genetic testing and muscle biopsy is diagnostic
General Management:
– No cure available
– Steroids slow muscle degeneration and anticonvulsants control seizures
– Aim to maximise quality of life with MDT approach
Duchenne muscular dystrophy
This is a type which is due to a X-linked recessive mutation in dystrophin
– The mutation is usually a serious nonsense or frameshift mutation
– Dystrophin connects the cytoskeleton of muscle fibres to the extracellular matrix through a protein complex in the cell membrane, stabilising the muscle cell membrane
– A lack of dystrophin results in reduced stability of muscle cells
– Over time, muscle cells become damaged, releasing creatinine kinase and Ca2+ enters, causing cell death
– This leads to muscular atrophy and replacement with fat and fibrotic tissue
Symptoms:
– Poor balance and progressive inability to walk
– Proximal progressive muscle weakness that occurs from around the ages of 4-5
– Gower’s sign –> using the arms to stand up from a squatting position
– Calf pseudohypertrophy
– Can have associated intellectual impairment
– Eventual death from cardiac/respiratory failure or dilated cardiomyopathy
Becker muscular dystrophy
This is very similar to Duchenne but is caused by a missense mutation in dystrophin
– This mutation means that one end of the protein dystrophin can anchor the cytoskeleton which means that the skeletal muscle is more stable than in Duchenne’s
– This is a less severe mutation and so give symptoms at a later age
Symptoms:
– Similar symptoms to Duchenne but symptoms start about 5 years later
– Less likely to have learning disabilities
Myotonic dystrophy
This is a dystrophy in which muscles contract but are unable to relax.
– It is an autosomal dominant condition due to a mutation in DMPK gene (type 1) or CNBP gene (type 2)
– In type 1, there is a trinucleotide expansion of GTG to over 50 repeats which lead to symptoms.
– Symptoms can appear from anytime from childhood to young adults
Symptoms:
– Worsening muscle loss and weakness –> muscles contract but inability to relax them
– Associated neurological symptoms –> Intellectual disability and cataracts
Cerebral palsy (CP)
This is a group of permanent motor disorders that appear early in childhood due to a damage of the developing motor neural pathways in the central nervous system.
– Whilst it is primarily a motor disorder, it is often accompanied by other symptoms to to damage to other neurological structures
Causes:
– Maternal infection –> associated with CMV and rubella
– Foetal infection –> neonatal meningitis
– Birth ischaemia –> asphyxia during birth, trauma
It is classified depending on the nature of the motor disorder:
Type | Site of Damage | Presentation |
Spastic | Upper motor neurons | Muscle stiffness, hypertonia, hyperreflexia |
Dyskinetic | Basal ganglia | Involuntary movements |
Ataxic | Cerebellum | Uncoordinated movements and poor balance |
Symptoms:
This gives general features + signs of the specific type of cerebral palsy:
– Delayed motor milestones –> children learn to roll over, sit, crawl and walk at a later age
– Problems with walking –> can display spastic gait, ataxic gait
– Persistence of the primitive reflexes
– May have associated learning difficulties, seizures, neurological problems (deafness)
Diagnosis:
– Clinical diagnosis based on history and physical examination. Can use MRI to establish cause
Management:
– Needs an MDT approach
– Aim is to help physical problems to maximise the patient’s independence with occupational therapy, physiotherapy, speech therapy
– If seizures –> use anticonvulsants
– For spasticity –> benzodiazepines (e.g., baclofen)